Examining the association between menstrual symptoms and health-related quality of life among working women in Japan using the EQ-5D

Abstract

Background Menstrual symptoms have been identified as a substantial burden among women of reproductive age, affecting their health status and quality of life globally. A range of menstrual symptoms have been studied as they affect the health-related quality of life (HRQoL), showing variations across specific menstrual symptoms and study settings. A major concern is demonstrated due to menstrual symptoms in women’s professional and social life, and consequently societal and economic loss for women and the society at large. Yet evidence is scarce that estimates the index form HRQoL score related to menstrual symptoms that is needed for health economic evaluations. Methods This study aims to investigate the association between menstrual symptoms and the HRQoL among working women in Japan in an index form, using a self-reporting questionnaire (n = 6048). The EQ-5D-3L (EuroQoL 5-dimension 3-level) is used that is a widely used tool to measure health outcomes for health economic evaluations globally. Multivariate regression analysis is conducted to assess the association between the HRQoL score and specific nineteen physical and mental conditions related to menstruation (e.g., pain, heavy bleeding, concentration, negative affect). Results The index form HRQoL score for menstrual symptoms is estimated as 0.682 in the study population (where a score one suggests perfect health). The association of the HRQoL score varies substantially across the menstrual symptoms. Several of the physical conditions and disorders show a substantial negative association with the HRQoL score. Also, most of the mental and psychological issues are significantly and negatively related to the HRQoL score. Conclusions This study suggests that HRQoL is substantially and negatively affected by menstruation among working women in Japan. Distinct variations of negative influences across menstrual symptoms underscore the multi-dimensional nature of menstruation and consequently the need of collective interventions to address these difficulties. The evidence of HRQoL continues to be an important area for future research on women’s health and health economic evaluations to inform effective and efficient resource allocations for relevant health policies and financing strategies.

Quality of Life after Risk-Reducing Hysterectomy for Endometrial Cancer Prevention: A Systematic Review

“…Women with HMB/DUB were found to have lower generic QoL than the age-matched general population, which is seen in other studies [ 90 , 91 , 92 ]. In all reporting studies, the QoL of patients improved following treatment by 6 months, and remained elevated for 5–10 years, in some studies higher than the age-matched population reference.…”

Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020–January, 2022: an observational cohort study

“…In studies conducted in Korea, Japan, and Ethiopia before the COVID-19 pandemic that specifically solicited responses about menstruation among women of reproductive age, the prevalence of menstrual irregularities was estimated to be between 14% and 33%. 27 , 28 , 29 The prevalence of postmenopausal bleeding among postmenopausal Danish women has been estimated to be 11%. 30 Stress, anxiety, and uncharacterised factors related to the COVID-19 pandemic might increase incidence of menstrual irregularities.…”

Heavy menstrual bleeding, iron deficiency, and iron deficiency anemia: Framing the issue

“…By definition, the symptom of HMB intermittently and directly interferes with one or a combination of a woman's physical, social, emotional, and material quality of life 1,32,33 . Women with HMB score significantly lower in studies using the widely validated SF‐36 (Short Form 36) instrument 33–40 . While HMB directly impacts women on an intermittent basis, when present, ID erodes quality of life every day, even in the absence of IDA 22,23,41–43 …”